Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Role of lncRNAs as prognostic markers of hepatic cancer and potential therapeutic targeting by S-adenosylmethionine via inhibiting PI3K/Akt signaling pathways.

Sadek KM, Lebda MA, Nasr NE, Nasr SM, El-Sayed Y.

Environ Sci Pollut Res Int. 2018 Jul;25(20):20057-20070. doi: 10.1007/s11356-018-2179-8. Epub 2018 May 10.

PMID:
29748795
2.

Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.

Frau M, Feo F, Pascale RM.

J Hepatol. 2013 Oct;59(4):830-41. doi: 10.1016/j.jhep.2013.04.031. Epub 2013 May 7. Review.

3.

Long Noncoding RNA lncARSR Promotes Doxorubicin Resistance in Hepatocellular Carcinoma via Modulating PTEN-PI3K/Akt Pathway.

Li Y, Ye Y, Feng B, Qi Y.

J Cell Biochem. 2017 Dec;118(12):4498-4507. doi: 10.1002/jcb.26107. Epub 2017 Jun 9.

PMID:
28464252
4.

Investigation of long noncoding RNAs expression profile as potential serum biomarkers in patients with hepatocellular carcinoma.

Kamel MM, Matboli M, Sallam M, Montasser IF, Saad AS, El-Tawdi AHF.

Transl Res. 2016 Feb;168:134-145. doi: 10.1016/j.trsl.2015.10.002. Epub 2015 Oct 24.

PMID:
26551349
5.

Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.

He Y, Meng XM, Huang C, Wu BM, Zhang L, Lv XW, Li J.

Cancer Lett. 2014 Mar 1;344(1):20-27. doi: 10.1016/j.canlet.2013.10.021. Epub 2013 Oct 30. Review.

PMID:
24183851
6.

Long non-coding RNA CRNDE promotes heptaocellular carcinoma cell proliferation by regulating PI3K/Akt /β-catenin signaling.

Tang Q, Zheng X, Zhang J.

Biomed Pharmacother. 2018 Jul;103:1187-1193. doi: 10.1016/j.biopha.2018.04.128. Epub 2018 May 7.

PMID:
29864897
7.

Augmented expression levels of lncRNAs ecCEBPA and UCA1 in gastric cancer tissues and their clinical significance.

Nasrollahzadeh-Khakiani M, Emadi-Baygi M, Nikpour P.

Iran J Basic Med Sci. 2017 Oct;20(10):1149-1158. doi: 10.22038/IJBMS.2017.9448.

8.

Serum long noncoding RNA urothelial carcinoma-associated 1: A novel biomarker for diagnosis and prognosis of hepatocellular carcinoma.

Zheng ZK, Pang C, Yang Y, Duan Q, Zhang J, Liu WC.

J Int Med Res. 2018 Jan;46(1):348-356. doi: 10.1177/0300060517726441. Epub 2017 Aug 31.

9.

Knockdown of long noncoding RNA urothelial cancer-associated 1 enhances cisplatin chemosensitivity in tongue squamous cell carcinoma cells.

Wang J, Li L, Wu K, Ge W, Zhang Z, Gong L, Yuan D.

Pharmazie. 2016 Oct 1;71(10):598-602. doi: 10.1691/ph.2016.6625.

PMID:
29441929
10.

Small nucleolar RNA ACA11 promotes proliferation, migration and invasion in hepatocellular carcinoma by targeting the PI3K/AKT signaling pathway.

Wu L, Zheng J, Chen P, Liu Q, Yuan Y.

Biomed Pharmacother. 2017 Jun;90:705-712. doi: 10.1016/j.biopha.2017.04.014. Epub 2017 Apr 15.

PMID:
28419966
11.

Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implications.

Niu ZS, Niu XJ, Wang WH.

World J Gastroenterol. 2017 Aug 28;23(32):5860-5874. doi: 10.3748/wjg.v23.i32.5860. Review.

12.

LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.

Wang Y, Kuang H, Xue J, Liao L, Yin F, Zhou X.

Biomed Pharmacother. 2017 Sep;93:1230-1237. doi: 10.1016/j.biopha.2017.07.024. Epub 2017 Jul 20.

PMID:
28738539
13.

Suppression of hepatocellular carcinoma by baculovirus-mediated expression of long non-coding RNA PTENP1 and MicroRNA regulation.

Chen CL, Tseng YW, Wu JC, Chen GY, Lin KC, Hwang SM, Hu YC.

Biomaterials. 2015 Mar;44:71-81. doi: 10.1016/j.biomaterials.2014.12.023. Epub 2015 Jan 12.

PMID:
25617127
14.

HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways.

Li Q, Wang C, Wang Y, Sun L, Liu Z, Wang L, Song T, Yao Y, Liu Q, Tu K.

J Exp Clin Cancer Res. 2018 Sep 19;37(1):231. doi: 10.1186/s13046-018-0908-y.

15.

Activation of phosphatidylinositol 3-kinase/Akt signaling mediates sorafenib-induced invasion and metastasis in hepatocellular carcinoma.

Wang H, Xu L, Zhu X, Wang P, Chi H, Meng Z.

Oncol Rep. 2014 Oct;32(4):1465-72. doi: 10.3892/or.2014.3352. Epub 2014 Jul 23.

PMID:
25070581
16.

Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.

Zhao X, Liu Y, Yu S.

Biochim Biophys Acta Mol Basis Dis. 2017 Jul;1863(7):1805-1816. doi: 10.1016/j.bbadis.2017.04.014. Epub 2017 Apr 18.

17.

Rab31 promoted hepatocellular carcinoma (HCC) progression via inhibition of cell apoptosis induced by PI3K/AKT/Bcl-2/BAX pathway.

Sui Y, Zheng X, Zhao D.

Tumour Biol. 2015 Nov;36(11):8661-70. doi: 10.1007/s13277-015-3626-5. Epub 2015 Jun 6.

PMID:
26044564
18.

Long Noncoding RNA FGFR3-AS1 Promotes Hepatocellular Carcinoma Carcinogenesis via Modulating the PI3K/AKT Pathway.

Zhuang J, He S, Wang G, Wang G, Ni J, Zhang S, Ye Y, Xia W.

Oncol Res. 2018 Sep 14;26(8):1257-1265. doi: 10.3727/096504018X15172756878992. Epub 2018 Feb 20.

PMID:
29463348
19.

Ets-2 regulates cell apoptosis via the Akt pathway, through the regulation of urothelial cancer associated 1, a long non-coding RNA, in bladder cancer cells.

Wu W, Zhang S, Li X, Xue M, Cao S, Chen W.

PLoS One. 2013 Sep 12;8(9):e73920. doi: 10.1371/journal.pone.0073920. eCollection 2013.

20.

miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.

Wang R, Yu Z, Chen F, Xu H, Shen S, Chen W, Chen L, Su Q, Zhang L, Bi J, Zeng W, Li W, Huang X, Wang Q.

Biomed Pharmacother. 2018 Jul;103:1632-1642. doi: 10.1016/j.biopha.2018.03.005. Epub 2018 May 7.

PMID:
29864952

Supplemental Content

Support Center